FDA approved Roctavian (valoctogene roxaparvovec), a gene therapy for hemophilia A, which is a congenital lack of Factor VIII. Factor VIII is critical for blood clotting. Hemophilia A is inherited in an X-linked recessive manner, which means it is passed down from mothers to sons
You are viewing a robot-friendly page.Click hereto reload in standard format.